title: Regression of hepatocellular carcinoma after treatment of hepatitis C: a case report.
abstract: Chronic hepatitis C induced cirrhosis predisposes to hepatocellular carcinoma (HCC). There is no data regarding the impact of hepatitis C treatment on HCC. We report a case of a 53-year-old man with chronic hepatitis C and HCC with lung metastasis who failed treatment with sorafenib but the tumor regressed after treatment of hepatitis C with ribavirin and sofosbuvir for 24 weeks.
authors.affiliation: Division of Hematology and Oncology, University of Virginia, Charlottesville, VA 22908, USA.
authors.forename: Emaculate
authors.initials: E
authors.lastname: Verla-Tebit
authors.affiliation: Division of Hematology and Oncology, University of Virginia, Charlottesville, VA 22908, USA.
authors.forename: Osama E
authors.initials: OE
authors.lastname: Rahma
keywords: Hepatocellular carcinoma (HCC); hepatitis C; ribavirin; sofosbuvir